Rare coexistence of three novel CDCA7-ALK, FSIP2-ALK, ALK-ERLEC1 fusions in a lung adenocarcinoma patient who responded to Crizotinib.
作者信息
Zhao Guojiang, Chen Lin, Xiao Mingzhe, Yang Shengli
机构信息
Department of Oncology and Hematology, Panzhihua Central Hospital, Panzhihua, 617000, China.
The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, 210002, China.
出版信息
Lung Cancer. 2021 Feb;152:189-192. doi: 10.1016/j.lungcan.2020.12.013. Epub 2020 Dec 14.
Abstract
摘要
Zotero 插件